{
    "2018-11-06": [
        [
            {
                "time": "2018-01-02",
                "original_text": "ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In AbbVie, Inc. To Contact The Firm",
                "features": {
                    "keywords": [
                        "ABBVIE",
                        "LEAD",
                        "PLAINTIFF",
                        "DEADLINE",
                        "ALERT",
                        "Faruqi & Faruqi",
                        "LLP",
                        "Investors",
                        "Losses",
                        "Contact"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Announces HUMIRAÂ® (adalimumab) Global Patent License with Momenta",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "HUMIRA",
                        "Global",
                        "Patent",
                        "License",
                        "Momenta"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "NOVEMBER 20 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "DEADLINE",
                        "Schall Law Firm",
                        "Class Action",
                        "Lawsuit",
                        "AbbVie",
                        "Investors",
                        "Losses"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Notable ETF Inflow Detected - DGRO, PFE, ABBV, CMCSA",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "DGRO",
                        "PFE",
                        "ABBV",
                        "CMCSA"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "telecommunications"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "See what the IHS Markit Score report has to say about AbbVie Inc.",
                "features": {
                    "keywords": [
                        "IHS",
                        "Markit",
                        "Score",
                        "report",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Today's Research Reports on Trending Tickers: AbbVie and AstraZeneca",
                "features": {
                    "keywords": [
                        "Research",
                        "Reports",
                        "Trending",
                        "Tickers",
                        "AbbVie",
                        "AstraZeneca"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}